Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Bailey

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Journal of Medicinal Chemistry|January 15, 2019
Tricyclic Indazoles-A Novel Class of Selective Estrogen Receptor Degrader AntagonistsJames S Scott, Andrew Bailey, David Buttar, et al.
Health Education Research|July 8, 2020
Adaptation of public health initiatives: expert views on current guidance and opportunities to advance their application and benefitSze Lin Yoong, Katarzyna Bolsewicz, Alice Grady, et al.
Journal of Medicinal Chemistry|April 5, 2017
Indazole-6-phenylcyclopropylcarboxylic Acids as Selective GPR120 Agonists with in Vivo EfficacyWilliam McCoull, Andrew Bailey, Peter Barton, et al.
Health Research Policy and Systems|January 1, 2020
Optimisation: defining and exploring a concept to enhance the impact of public health initiativesLuke Wolfenden, Katarzyna Bolsewicz, Alice Grady, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2007
From ATP to AZD6140: the discovery of an orally active reversible P2Y12 receptor antagonist for the prevention of thrombosisBrian Springthorpe, Andrew Bailey, Patrick Barton, et al.
Journal of Medicinal Chemistry|June 15, 2019
Discovery of a Thiadiazole-Pyridazine-Based Allosteric Glutaminase 1 Inhibitor Series That Demonstrates Oral Bioavailability and Activity in Tumor Xenograft ModelsM Raymond V Finlay, Mark Anderton, Andrew Bailey, et al.
Journal of Medicinal Chemistry|June 21, 2023
Correction to "Discovery of a Thiadiazole-Pyridazine-Based Allosteric Glutaminase 1 Inhibitor Series That Demonstrates Oral Bioavailability and Activity in Tumor Xenograft Models"M Raymond V Finlay, Mark Anderton, Andrew Bailey, et al.
Ecology Letters|August 25, 2025
Forest Age Rivals Climate to Explain Reproductive Allocation Patterns in Forest Ecosystems GloballyRachel E Ward, Huanyuan Zhang-Zheng, Kate Abernethy, et al.
JAMA|January 30, 2025
Adjuvant Atezolizumab for Early Triple-Negative Breast Cancer: The ALEXANDRA/IMpassion030 Randomized Clinical TrialMichail Ignatiadis, Andrew Bailey, Heather McArthur, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Journal of Medicinal Chemistry|January 15, 2019
Tricyclic Indazoles-A Novel Class of Selective Estrogen Receptor Degrader AntagonistsJames S Scott, Andrew Bailey, David Buttar, et al.
Health Education Research|July 8, 2020
Adaptation of public health initiatives: expert views on current guidance and opportunities to advance their application and benefitSze Lin Yoong, Katarzyna Bolsewicz, Alice Grady, et al.
Journal of Medicinal Chemistry|April 5, 2017
Indazole-6-phenylcyclopropylcarboxylic Acids as Selective GPR120 Agonists with in Vivo EfficacyWilliam McCoull, Andrew Bailey, Peter Barton, et al.
Health Research Policy and Systems|January 1, 2020
Optimisation: defining and exploring a concept to enhance the impact of public health initiativesLuke Wolfenden, Katarzyna Bolsewicz, Alice Grady, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2007
From ATP to AZD6140: the discovery of an orally active reversible P2Y12 receptor antagonist for the prevention of thrombosisBrian Springthorpe, Andrew Bailey, Patrick Barton, et al.
Journal of Medicinal Chemistry|June 15, 2019
Discovery of a Thiadiazole-Pyridazine-Based Allosteric Glutaminase 1 Inhibitor Series That Demonstrates Oral Bioavailability and Activity in Tumor Xenograft ModelsM Raymond V Finlay, Mark Anderton, Andrew Bailey, et al.
Journal of Medicinal Chemistry|June 21, 2023
Correction to "Discovery of a Thiadiazole-Pyridazine-Based Allosteric Glutaminase 1 Inhibitor Series That Demonstrates Oral Bioavailability and Activity in Tumor Xenograft Models"M Raymond V Finlay, Mark Anderton, Andrew Bailey, et al.
Ecology Letters|August 25, 2025
Forest Age Rivals Climate to Explain Reproductive Allocation Patterns in Forest Ecosystems GloballyRachel E Ward, Huanyuan Zhang-Zheng, Kate Abernethy, et al.
JAMA|January 30, 2025
Adjuvant Atezolizumab for Early Triple-Negative Breast Cancer: The ALEXANDRA/IMpassion030 Randomized Clinical TrialMichail Ignatiadis, Andrew Bailey, Heather McArthur, et al.
Pageof 6